Many flavoproteins are non-covalent complexes between FMN and an apoprotein. To understand better the stability of flavoproteins, we have studied the energetics of the complex between FMN and the apoflavodoxin from Anabaena PCC 7119 by a combination of site-directed mutagenesis, titration calorimetry, equilibrium binding constant determinations, and x-ray crystallography. Comparison of the strength of the wild type and mutant apoflavodoxin-FMN complexes and that of the complexes between wild type apoflavodoxin and shortened FMN analogues (riboflavin and lumiflavin) allows the dissection of the binding energy into contributions associated with the different parts of the FMN molecule. The estimated contribution of the phosphate is greatest, at 7 kcal mol ؊1 ; that of the isoalloxazine is of around 5-6 kcal mol ؊1 (mainly due to interaction with Trp-57 and Tyr-94 in the apoprotein) and the ribityl contributes least: around 1 kcal mol ؊1 . The stabilization of the complex is both enthalpic and entropic although the enthalpy contribution is dominant. Both the phosphate and the isoalloxazine significantly contribute to the enthalpy of binding. The ionic strength does not have a large effect on the stability of the FMN complex because, although it weakens the phosphate interactions, it strengthens the isoalloxazine-protein hydrophobic interactions. Phosphate up to 100 mM does not affect the strength of the riboflavin complex, which suggests the isoalloxazine and phosphate binding sites may be independent in terms of binding energy. Interestingly, we find crystallographic evidence of flexibility in one of the loops (57-62) involved in isoalloxazine binding.
Many proteins use tightly bound cofactors to perform their biological functions. Flavoproteins, redox proteins carrying a flavin group, are one example (1) . Although there are several flavoproteins where the flavin is covalently bound (2) , the large majority consist on tight, but non-covalent, complexes of apoprotein and flavin. The flavins in flavoproteins derive from riboflavin and come in two lengths. The short one, flavin mono-nucleotide (FMN; Fig. 1 ) is just 5Ј phosphoriboflavin; the long one is flavin adenine dinucleotide (FAD). In either flavin, the redox properties are confined to the isoalloxazine ring, the rest of the molecule being important for binding. FMN and FAD are not usually interchangeable. On binding to the protein, the redox properties of the flavin are tailored to suit the particular requirements of the redox reaction where the protein is involved (3) (4) (5) .
One of the smallest and better known flavoproteins is flavodoxin. Flavodoxin is an ␣/␤ electron transfer protein, involved in both photosynthetic and non-photosynthetic reactions, that carries a molecule of non-covalently bound FMN as its only redox center (6, 7) . The FMN can be removed from the protein, and the resulting apoflavodoxin can be easily reconstituted. Although there are several studies on the interaction of FMN with apoflavodoxins (4, 6, 8 -10), a detailed analysis of the energetics of the complex is lacking. We are using the flavodoxin from Anabaena PCC 7119 as a model for protein folding and binding studies. The gene of the protein has been cloned and can be expressed in Escherichia coli (11) , the structure of the holo and apo forms are known (Refs. 12-14; see Figs. 2 and 3), and the stability of apoflavodoxin in solution has been characterized (15, 16) . The flavodoxin from Anabaena constitutes an ideal model to investigate the energetics of protein/ flavin interaction. In this paper we dissect the binding energy of the complex to show the contribution of the three parts of the FMN molecule (the isoalloxazine, the ribityl, and the phosphate; Fig. 1 ) and that of several residues of the protein using flavodoxin mutants and FMN analogues, and we quantify the enthalpic and entropic components of the binding energy using titration calorimetry. In addition, we report an alternative conformation of the 57-62 isoalloxazine binding loop in a mutant apoflavodoxin, which suggests this loop could be flexible in solution.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis-The mutant flavodoxins W57Y, W57F, W57L, W57A, Y94W, Y94F, Y94L, and Y94A (4) were prepared by oligonucleotide-directed mutagenesis of the Anabaena PCC 7119 flavodoxin gene using the method of Deng and Nickoloff (17) as implemented in the Transformer TM kit (version 2) from CLONTECH. The mutants T12V and T15V have been prepared by the same procedure using the following oligonucleotides: T12V, 5Ј-CAGTTTTACCAACTT-GAACACCGTAG-3Ј; T15V, 5Ј-GCTACTGATTCAACTTTACCAGTTTG-AG-3Ј.
Expression and Purification of the Flavodoxin Mutants-Expression and purification of wild type and mutant flavodoxins (in the holo form) were done essentially as described (15) . Apoflavodoxins were subsequently prepared by treatment with 3% trichloroacetic acid (18) , followed by fast protein liquid chromatography purification if necessary. Each apoflavodoxin preparation was Ͼ95% pure by SDS-polyacrylamide gel electrophoresis.
Protein Concentration-The concentration of wild type apoflavodoxin in solution was determined using an extinction coefficient (280 nm) of 34.1 Ϯ 0.5 mM Ϫ1 cm Ϫ1 (15) determined by the method of Gill and von Hippel (19) . Since this extinction coefficient hardly deviates from the theoretical one that can be calculated from the total amount of tyrosine and tryptophan residues in the protein (33.0 mM Ϫ1 cm Ϫ1 ), we have quantified the concentration of the apoflavodoxin mutants from their theoretical extinction coefficients.
Equilibrium Sedimentation-The state of association of wild type apoflavodoxin in 50 mM Mops, 1 pH 7.0, was investigated by equilibrium sedimentation measurements at 25.0 Ϯ 0.1°C using a Beckman ultracentrifuge. The apoflavodoxin concentrations used were 60 and 120 M. Data analysis was performed using the EQASSOC program (20) .
Dissociation Constants-The dissociation constants of the complexes between FMN (or the FMN analogues riboflavin and lumiflavin) and apoflavodoxin were determined by titration of the flavin solution with apoflavodoxin at 25 Ϯ 0.1°C in darkness. The quenching of flavin fluorescence was followed to monitor flavin binding. The FMN was either supplied by Sigma and further purified by HPLC, or came directly from holoflavodoxin. In either case it was Ͼ95% pure according to reverse phase HPLC. Riboflavin and lumiflavin were supplied by Sigma and used without further purification. In a typical experiment, 1 ml of 0.2 M FMN in 50 mM Mops, pH 7.0, was titrated with aliquots of 5-300 M apoflavodoxin (depending on the mutant). For the riboflavin (lumiflavin) binding experiments, 0.2 M (10 M) flavin solutions in the same buffer were titrated with 600 -2500 M apoflavodoxin solutions. For each experiment, the reported value of ionic strength was calculated in the conventional way from the known ionic composition of the solution.
The dissociation constants were calculated as described (4). The following equation was used to fit the observed fluorescence as a function of apoflavodoxin concentration in the solution.
F is the observed emission intensity after each addition, F end the remaining emission intensity at the end of the titration, F ␦ the difference in emission intensity between 1 M free flavin and 1 M flavodoxin, C A the total protein concentration after each addition (apo ϩ holo), K d the dissociation constant of the apo-flavin complex in M units, C F the starting concentration of flavin, and d the dilution factor of this initial concentration (initial volume/total volume) after each addition. This fitting treats the initial concentration of flavin as an unknown. In all cases the initial concentration of flavin was correctly predicted (within 90%).
Titration Calorimetry-Calorimetric studies of the apoflavodoxin-FMN complex were performed using a titration calorimeter described elsewhere (21) . The instrument is of the heat conduction type. The protein sample is usually placed in a reaction bulb of 203 l, where small volume injections of ligand are made (5-10 l each). A complete titration curve is thus obtained that, for protein-ligand affinities in the 10 2 to 10 7 M Ϫ1 range, can be analyzed to yield the enthalpy change and binding constant (22) . In the apoflavodoxin-FMN interaction, however, since the affinities in most of the complexes studied are above the upper limit, only the enthalpy change could be obtained from calorimetry. In all the experiments, apoflavodoxin was placed in the reaction bulb at concentrations around 0.1 mM, and 10-l injections of FMN at concentrations around 2 times higher were made. Light exposure of FMN solutions was kept to a minimum during the experiment. Data fitting was carried out with a program developed in our laboratory based on the Simplex algorithm (23) . The standard errors reported were calculated by the Bevington method (24) .
X-ray Crystallography-The W57A apoflavodoxin mutant was crystallized at a concentration of 16 mg/ml at room temperature in 3.2 M ammonium sulfate, 100 mM sodium, potassium phosphate, pH 6.0, using the vapor diffusion technique. The plate-like crystals belong to the monoclinic space group P21, and have cell constants a ϭ 74.14 Å, b ϭ 55.52 Å, c ϭ 75.18 Å, ␤ ϭ 107.04°. Calculation of Matthews parameter (25) gave a V m of 1.92 for four monomers per asymmetric unit.
A complete x-ray data set to 2.05-Å resolution was collected from one single crystal mounted together with its mother liquor in a capillary on an imaging plate scanner (Mar Research) at room temperature, using monochromatized CuK ␣ radiation produced by a conventional rotating anode. Reflections were evaluated, merged, and scaled with DENZO (26), and data reduction was performed with the program TRUNCATE from the CCP4 program suite (27) . The crystallographic data and their statistics are shown in Table VIII .
The structure of the mutant was solved by molecular replacement with AMoRe (28) by searching independently for the orientation and position of the four independent monomers. The model of the wild type apoflavodoxin (code 1FTG) was used as the search model. The rotation and translation functions were computed using data between 8.0-and 4.0-Å resolution. The rotational search showed two solutions with correlation values of 10.3 and 9.9 . Translational searching and rigid body fitting for these two solutions resulted in a correlation value of 0.62, with four independent molecules arranged as a pair of dimers.
The initial model was further optimized by one round of rigid body refinement with X-PLOR (29), followed by energy-restrained positional refinement. The stereochemical parameters derived from Engh and Huber (30) were used throughout. The model was completed in several cycles consisting of electron density calculation, remodeling on a SGI graphics workstation using TurboFRODO (31) , and restrained crystallographic refinement including slow cooling using X-PLOR (32) and SHELXL-97 (33) . Water molecules were added and refined individually where they were stereochemically plausible and both 2F o Ϫ F c and F o Ϫ F c difference Fourier maps showed a density of more than 1.0 and 2.0 , respectively.
RESULTS

Monomeric Character of Apoflavodoxin in Binding Assay
Conditions-Wild type apoflavodoxin in 50 mM Mops, pH 7.0, is a monomer from 0.5 to 25 M, as demonstrated by the independence of its conformational stability of protein concentration in this range (15) . We have investigated if the apoprotein remains monomeric at higher protein concentrations by equilibrium sedimentation analysis. The calculated molecular mass of apoflavodoxin in a 60 M and in a 120 M solution in 50 mM Mops, pH 7.0, was 18,500 Ϯ 400 and 18,300 Ϯ 300, respectively, in good agreement with the theoretical mass (18, 885) , and no deviations from the expected distribution for a monomeric species is observed (data not shown). This indicates that wild type apoflavodoxin in 50 mM Mops, pH 7.0, is a monomer in the concentration range used in this study. We have assumed for our analyses that the protein remains monomeric in the presence of up to 0.5 M NaCl and that mutant flavodoxins are also monomeric.
Dissociation Constants of Wild Type and Mutant Apoflavodoxin-Flavin Complexes-The dissociation constants at 25.0 Ϯ 0.1°C of the FMN-apoflavodoxin complexes, in the absence of phosphate, have been determined for wild type flavodoxin and the 10 mutants in 50 mM Mops, pH 7.0 (Table I; see Fig. 4a for the wild type complex). All mutations decrease the affinity of apoflavodoxin for FMN. Mutations at the tryptophan site similarly decrease the strength of the complex by about 2 kcal mol Ϫ1 , and, as a consequence, the four mutant proteins have the same affinity for FMN within 0.7 kcal mol Ϫ1 . In contrast, the effect of mutating the tyrosine on the affinity of the complex depends on the type of residue that is introduced. When tyrosine is mutated to an aromatic residue, the complex becomes similarly destabilized (0.8 kcal mol Ϫ1 weaker with phenylalanine and 1.5 kcal mol Ϫ1 weaker with tryptophan at position 94), but when the tyrosine is replaced by either leucine or alanine, marked decreases in the strength of the complex are observed. Replacement of Tyr-94 by alanine lowers the affinity by 4 kcal mol Ϫ1 . This mutant protein is still purified as a holoflavodoxin. Replacement of Tyr-94 by leucine lowers the affinity by as much as 8 kcal mol Ϫ1 . This mutant protein loses the FMN as the purification proceeds and is thus obtained essentially as the apoflavodoxin. The dissociation constants of the wild type and the aforementioned mutant apoflavodoxin-FMN complexes in 50 mM Mops, pH 7.0, follow the same trend as those reported for the same complexes in 50 mM potassium phosphate (4), although the complexes are, on average, 0.4 kcal mol Ϫ1 weaker in Mops than in phosphate. Finally, the two mutations introduced at the phosphate binding site, T12V and T15V, destabilize the apoflavodoxin-FMN complex by 4 and 2 kcal mol Ϫ1 , respectively.
The dissociation constants of the apoflavodoxin-riboflavin complexes at 25.0 Ϯ 0.1°C have been determined for wild type flavodoxin and seven mutants (Table II; see Fig. 4b for the wild type complex). Wild type apoflavodoxin binds riboflavin 1.2 ϫ 10 5 -fold more weakly (there is a difference in stability of 7.0 kcal mol Ϫ1 ) than FMN. As in the FMN complex, the effect of mutating Tyr-94 or Trp-57 on the stability of the apoflavodoxin-riboflavin complexes is different. When tyrosine is mutated to an aromatic residue, the complex becomes about 1 kcal mol Ϫ1 weaker, but when tryptophan is replaced by an aromatic residue, the stability of the complex changes little. When the tryptophan is replaced by an alanine, the complex becomes destabilized by 0.4 kcal mol Ϫ1 . As for the phosphate binding site, the T12V mutation destabilizes the complex by 0.5 kcal mol Ϫ1 while the T15V mutation has no effect.
Wild type apoflavodoxin binds lumiflavin 8 ϫ 10 5 -fold more weakly (Fig. 4b ) than FMN (a difference of 8.1 kcal mol Ϫ1 ) but just 6-fold (1.1 kcal mol Ϫ1 ) more weakly than riboflavin (Table  II) . The complexes between lumiflavin and the T12V and T15V mutants are slightly more stable than the wild type complex.
Influence of the Ionic Strength on the Dissociation Constant of the Wild Type Apoflavodoxin-Flavin Complexes-
The wild type apoflavodoxin-FMN complex is slightly less stable at high ionic strength than at low strength; there is a difference of 0.7 kcal mol Ϫ1 between 1.9 and 500 mM ionic strength (Table III) . This effect is almost completed at 50 mM ionic strength, and no major changes occur from 50 to 500 mM. In contrast, the wild type apoflavodoxin-riboflavin complex is stabilized as the ionic strength is raised, the difference in stability between 1.9 and 500 mM being of 2.6 kcal mol Ϫ1 (Table III) . As in the case of the FMN complex, the effect of the ionic strength is mainly exerted in the low ionic strength region.
Influence of Phosphate on the Dissociation Constants of the Wild Type Apoflavodoxin-FMN and Apoflavodoxin-Riboflavin
Complexes-The effect of phosphate on the strength of the complex at constant ionic strength (500 mM) has been examined. Low concentrations of sodium phosphate (1-10 mM) stabilize the apoflavodoxin-FMN complex by about 1 kcal mol Ϫ1 while an additional increase in the phosphate concentration is destabilizing (Table IV) . Sodium phosphate (1-100 mM) does not exert any effect on the stability of the apoflavodoxin-riboflavin complex (Table IV) .
Enthalpies and Heat Capacities of Binding-Enthalpy changes at pH 7.0 and different temperatures have been measured for the reaction of wild type apoflavodoxin and six mutants with FMN. Table V shows the results for the wild type form at 25°C. Mops buffers in the experiments shown in the table were prepared from the commercial sodium salt, which implies an ionic strength around 50 mM when no NaCl was present and around 100 mM in the presence of 50 mM NaCl. In an experiment in 50 mM Mops, pH 7.0, prepared from the free acid, (ionic strength around 20 mM), a value of Ϫ11.0 Ϯ 0.2 kcal mol Ϫ1 for the enthalpy change was measured (data not shown). There is not a significant difference between this value and the ones reported in Table V (Table V) . In a third experiment using imidazole buffer at the same ionic strength, a similar value of Ϫ10.7 Ϯ 0.4 kcal mol Ϫ1 , was obtained (Table V) . As the three buffers have quite different ionization enthalpy changes (1.2 kcal mol Ϫ1 for orthophosphate, 5.2 kcal mol Ϫ1 for Mops, and 8.7 kcal mol Ϫ1 for imidazole), our results indicate that there is no proton uptake or release linked to FMN binding to apoflavodoxin in our experimental conditions.
The enthalpy changes of the complexes between several apoflavodoxin mutants and FMN in 50 mM sodium phosphate buffer at pH 7.0 are shown in Table VI . With the only exception of Y94W, all the mutants show a decrease in the enthalpy change relative to wild type. We have also determined, for wild type and several mutants, the enthalpy change at different temperatures. From the results obtained for the wild type complex (⌬H ϭ Ϫ5.8, Ϫ11.8, and Ϫ16.6 kcal mol Ϫ1 at 15°C, 25°C, and 33°C, respectively) we calculate a heat capacity change of Ϫ600 Ϯ 20 cal/K Ϫ1 mol Ϫ1 for FMN binding (Table VI) . Negative heat capacities changes were found for all the mutant complexes (Table VI) , as expected for a binding process (34) . Entropy changes of the mutant complexes calculated from enthalpy changes (Table VI) and standard Gibbs energy changes (Table I) are also shown in Table VI .
Our attempts to measure the enthalpy of the apoflavodoxinriboflavin complex by titration calorimetry have failed due to a low solubility of riboflavin (higher flavin concentrations are required to form the riboflavin complex than for the FMN complex while the solubility of riboflavin is lower) and a small enthalpy change (see below). We have nevertheless calculated the enthalpy of the wild type apoflavodoxin-riboflavin complex in 50 mM Mops, pH 7.0, from the slope of a Van't Hoff plot ( Calculation of Structural Parameters of Apoflavodoxin-FMN Complexes from Calorimetric Data-The calorimetric data gathered for the apoflavodoxin-FMN complex can be used to calculate structural parameters using semiempirical equations that relate heat capacity, enthalpy, and entropy changes with changes in apolar and polar surface areas accessible to solvent (34 -37) . The change in heat capacity for a protein-ligand interaction is the basic parameter in the interpretation of thermodynamic data in structural terms. It mainly reflects contributions from interactions with the solvent, and it has been parametrized in terms of changes of apolar and polar surface areas accessible to the solvent (35) . ⌬ASA ap and ⌬ASA pol are the changes of apolar and polar surface areas accessible to the solvent (in Å 2 ), and ⌬Cp is expressed in cal K Ϫ1 mol Ϫ1 . The change in enthalpy for the unfolding of model proteins has also been parametrized in terms of changes in apolar and polar accessible surface areas (36) . and 3 are reported in Table VII . All the areas calculated so are negative (implying surface burial) and large; their magnitude is in the order of association processes in proteins (see, for example, Table II in Ref. 34) . Changes in entropy associated to a protein ligand interaction are usually interpreted in terms of three contributions: (a) the change of conformational entropy, ⌬S conf , (b) the loss of translational and rotational entropy when the ligand binds, ⌬S tr , and (c) the change in hydration entropy associated to the interaction with the solvent of polar and apolar groups in the protein. This latter contribution has also been parametrized in terms of apolar and polar accessible surface areas (37) , so that the entropy change at 25°C (in cal K Ϫ1 mol Ϫ1 ) can be expressed as shown by Equation 4 . Using the experimental value for ⌬S 25 and the values for ⌬ASA ap and ⌬ASA pol already calculated, we obtain for ⌬S conf the values reported in the last two columns of Table VII . Two values for ⌬S conf are given in each case, as two different values for ⌬S tr have been used: Ϫ50 cal K Ϫ1 mol Ϫ1 (34), which reflects mainly a loss of translational entropy; or the smaller value of Ϫ8 cal K Ϫ1 mol Ϫ1 (38, 39) . In either case the values calculated are large, suggesting a significant conformational change upon ligand binding. For instance, if we use the value previously employed by Spolar and Record for the conformational entropy change associated to protein unfolding (Ϫ5.6 cal K Ϫ1 mol residue Ϫ1 ), we find that, in terms of conformational entropy, the conformational change would be equivalent to the folding of about 50 residues (for a protein with 169 residues). X-ray Structure of W57A Apoflavodoxin-W57A apoflavodoxin from Anabaena is a tetramer of four identical subunits with 169 residues each. The tetramer can also be described as a dimer of dimers with each monomer tightly bound to a second monomer. The four non-crystallographic symmetry-related subunits have virtually identical structures, as evidenced by the low root-mean-square differences between C␣ carbons. Appreciable differences between the non-crystallographic symmetry-related subunits only arise either from residues located in the flexible region Gly-27-Val-30 (normally associated with high B-factors), or from residues involved in molecular packing. The model contains one sulfate (or phosphate) ion per monomer and 329 water molecules in the asymmetric unit. All residues lay in allowed regions of the Ramachandran plot, the vast majority laying in the most favorable regions.
The W57A apoflavodoxin folds (Table VIII, Figs. 2 and 3 ) in a compact, single domain, ␣/␤ structure that is very similar to both the apo-wild type and holo-wild type flavodoxin structures (14 and 12, respectively). The most striking difference between the W57A structure and those of the wild type apo and holoflavodoxins is a large displacement of the surface located loop, involved in FMN binding, that bears the mutation. The C␣ positions of the six residues from Trp-57 to Leu-62 deviate by Ͼ1 Å from the the holo and apo wild type structures; at the apex of the loop, the C␣ atom of Ala-60 is displaced by 5 Å. The displacement is not a rigid body movement and the main chain conformation is altered significantly. A superimposition of the FMN binding site of the three structures is shown in Fig. 2 . The side chain of Tyr-94 protrudes into the specificity pocket at the same position as that observed in the wild type apoprotein, and forms a hydrogen bond (2.97 Å) with the main chain carbonyl of Asn-58. It is noteworthy that the flipping of the Trp-57-Asp-58 peptide bond in the wild type apoflavodoxin, that throws the hydrophobic Trp-57 side chain into the cavity (14) is not observed in the W57A mutant. Instead, the Ala-57 main chain conformation in W57A corresponds to that observed for the tryptophan in the holoprotein. The ensuing cavity originated in the mutant by the absence of the tryptophan side chain is partially filled by a reorientation of Gln-11, that moves toward the position occupied by the tryptophan in the wild type apoprotein. As a result of this reorientation, the carboxamide nitrogen and oxygen atoms of Gln-11 form hydrogen bonds with the carbonyl of Thr-56 (2.91 Å) and with the main chain nitrogen of Asn-58 (2.99 Å), respectively, thus stabilizing the rearrangement of the 57-62 loop. Compared with the wild type apoflavodoxin, the isoalloxazine binding site is more accessible 
a Values of translational entropy used in the calculations were Ϫ50 cal K Ϫ1 mol Ϫ1 in a and Ϫ8 cal K Ϫ1 mol Ϫ1 in b. to solvent in the W57A mutant ( Fig. 3 ). Finally, as already observed in the wild type apoprotein, the side chain of Lys-14 extends toward the carboxylate of Asp-146 forming a salt bridge, and a sulfate (or phosphate) group binds to apoW57A mimicking the interaction of the phosphate in FMN when it is bound in wild type holoflavodoxin.
DISCUSSION
Possible Flexibility of the 57-62, Tryptophan-bearing, Isoalloxazine Binding Loop-Comparison of the structures of the wild type holo (12) and apo flavodoxins (14) revealed that, in the absence of FMN, one of the two loops involved in the binding of the FMN isoalloxazine adopts an alternate conformation that allows Trp-57 to interact with Tyr-94, closing the isoalloxazine binding site (14) . It was not clear, however, how important that interaction was for the loop to adopt that conformation. We have now solved the structure of the W57A apoflavodoxin mutant where the tryptophan side chain has been replaced by an alanine. In this mutant the 57-62 loop adopts yet a different conformation where the alanine peptide bonds resemble those of the holoprotein but other residues in the loop move away from the wild type conformation (holo and apo) and form new loop stabilizing interactions. This suggests that the peptide flip observed in the wild type apo form, relative to the holo form, is caused by the Trp-57/Tyr-94 interaction rather than by the removal of the FMN itself. The fact that, in the absence of the Trp-57/Tyr-94 interaction (W57A mutant), the loop can adopt a third different conformation, stabilized by new hydrogen bonds, suggests that this loop is a flexible region that can adopt different conformations of presumably similar energy. The flexibility of this loop, is also suggested by NMR solution studies 2 and has been reported from NMR studies for the equivalent loop of the Azotobacter apoflavodoxin (Ref. 40 ; this flavodoxin, however, does not contain the conserved tryptophan). A possible role of this loop flexibility in the mechanism of FMN binding remains to be determined.
In the next section, we discuss the effect of mutating Trp-57 and Tyr-94 on the energetics of the apoflavodoxin-FMN complex. To be able to draw conclusions on the role of the different amino acid residues on the stabilization of bound FMN, the structure (more precisely the energetics; see Ref. 4) of the different mutant apoflavodoxins should not be altered by the mutations. Neither removal of the FMN nor mutation of the neighboring Trp-57 significantly alters the structure of the Tyr-94 bearing loop. We assume thus that this loop is not particularly flexible and that mutations of the tyrosine will not result in major rearrangements. The 57-62 loop is different, and we have observed a reorganization both on removal of the FMN and of the side chain of Trp-57. In the W57A apoflavodoxin mutant, the Trp-57/Tyr-94 interaction observed in the wild type apoflavodoxin is obviously absent, but new interactions appear instead (two hydrogen bonds, see above section). This means that, for this mutant to adopt the conformation that binds FMN (that will be assumed the same in all the mutants; see Ref. 41) , different interactions need to be broken than in the wild type apoflavodoxin. This introduces some uncertainty in the analysis of the energetic effects observed at this position (position 57). We will assume for further analysis that this effect is small and will provide some evidence in the next section. As for the phosphate binding site, the holo and apo wild type flavodoxins are essentially identical in this region. Interestingly, although mutation of Trp-57 to alanine alters the structure of one of the isoalloxazine binding loops, it does not affect sulfate/phosphate binding (the W57A structure also contains one such group bound). This suggests that muta-tions at the isoalloxazine binding regions do not affect the phosphate binding region (inasmuch as we can determine). Because of this, even if the phosphate region is less organized in solution than indicated by the available x-ray structures, it is reasonable to assume that mutations at the isoalloxazine binding region will not change its conformation. As for the mutations at the phosphate binding site, they are isosteric, and therefore we expect them to be tolerated.
Contribution of the Isoalloxazine to the Stability of the Apoflavodoxin-FMN Complex-The isoalloxazine of FMN binds to apoflavodoxin by intercalating between two aromatic residues: Trp-57 and Tyr-94. These residues are well conserved, especially the tyrosine, among the different flavodoxins, and their role in the regulation of flavodoxin redox potentials has been discussed elsewhere (4) . We have measured the contribution of these aromatic residues to the binding of FMN by mutating them to other residues and determining the effect on the stability of the complex. The stability of those complexes has been reported in phosphate buffer (4) . Here we report the stability in Mops buffer, which allows us to investigate any possible effect of phosphate on the stability of the complex. There is one mutation, Y94L, that destabilizes the complex most. We think that this simply reflects that the branched side chain of leucine does not fit well on the space previously occupied by the tyrosine, and that a similar strongly destabilizing effect is not observed on the W57L mutation because, unlike Tyr-94, Trp-57 lays on the surface of the protein. Assuming that deleting the side chains of Trp-57 and Tyr-94 by mutating these residues to alanine does not significantly alter either the energetics of the apoprotein (see previous section; also see Ref. 4 for relevant spectroscopic evidence and further discussion on the relevance of this point) or the structure of their complexes with FMN (there is NMR evidence that this is the case in the equivalent mutation Y98A of Desulfovibrio vulgaris flavodoxin; see Ref. 41) , we can estimate the contribution of the interaction between Tyr-94 and the isoalloxazine from the stability difference of the wild type and Y94A FMN complexes. This contribution is of around 4 kcal mol Ϫ1 . Similarly, we estimate the contribution of the Trp-57-isoalloxazine interaction at about 2 kcal mol Ϫ1 . Assuming the two contributions are additive, the combined effect of the two aromatic residues on the binding of the isoalloxazine is of around 6 kcal mol Ϫ1 . We have tested if these assumptions are reasonable by measuring directly the dissociation constant of the complex between wild type apoflavodoxin and lumiflavin in the same buffer conditions because lumiflavin is just isoalloxazine-methylated at position 10. The strength of the apoflavodoxin-lumiflavin complex is of 5 kcal mol Ϫ1 . The good correspondence between this value and the one calculated from the mutational analysis confirms the aforementioned assumptions and suggests that Trp-57 and Tyr-94 are the only important residues contributing to the binding of the isoalloxazine of FMN.
Contribution of the Phosphate to the Stability of the Apoflavodoxin-FMN Complex-FMN is 5Ј-phosphoriboflavin. The FMN phosphate binds to apoflavodoxin by establishing hydrogen bonds with several backbone NH (11 to 15) and with the side chains of Thr-12 and Thr-15 at the N terminus of the N-terminal helix (14 to 26) and the preceding reverse turn (10 to 13) . The binding at the helix end and the interaction with the threonine side chains is well conserved among the different flavodoxins. The overall contribution of the phosphate group in FMN to the stability of the apoflavodoxin-FMN complex can be determined from the difference in stability between this complex and that of the apoflavodoxin-riboflavin complex. This difference is of about 7 kcal mol Ϫ1 for the wild type complexes and varies from 5 to 7 kcal mol Ϫ1 for the mutant complexes.
The contribution of the FMN phosphate to the stability of the complex with apoflavodoxin seems thus to be larger than that of the entire isoalloxazine fused ring. In an attempt to further dissect the interaction energy of the phosphate group of FMN with the protein, we have mutated two side chains (Thr-12 and Thr-15) that form hydrogen bonds of similar length with the phosphate, to isosteric valines. Of these threonine residues, Thr-12 is more exposed to solvent. It is thus surprising that removal of the Thr-12 hydroxyl lowers the affinity of the complex twice as much as removal of the corresponding Thr-15 hydroxyl. On the other hand, the fact that removal of just 2 out of the 9 hydrogen bonds formed by the phosphate with the protein destabilizes the complex by 4 and 2 kcal mol Ϫ1 (when the overall interaction energy is of around 7 kcal mol Ϫ1 ) suggests that either the interaction energy of the hydrogen bonds formed by the phosphate is not additive but cooperative or that some additional perturbations are introduced in the phosphate binding site by the mutations. Further mutational and structural studies are required to check this point and to clarify possible cooperative effects between the hydrogen bonds that hold the phosphate FMN in place.
Contribution of the Ribityl to the Stability of the Apoflavodoxin-FMN Complex-The ribityl binding site is the least conserved region of the FMN binding site in flavodoxins. In Anabaena flavodoxin the ribityl is hydrogen-bonded to Thr-56, Thr-88, Asp-146, and to water molecules at the surface of the protein, while in the highly homologous Anacystis flavodoxin all the hydrogen bonds are with water molecules (12, 42) . The contribution of ribityl-apoflavodoxin interactions to the strength of the apoflavodoxin-FMN complex can be estimated from the difference in binding energies between the riboflavin and the lumiflavin apoflavodoxin complexes. This difference is of about 1 kcal mol Ϫ1 for the wild type complex.
Effect of Ionic Strength and Phosphate Concentration on the Apoflavodoxin-FMN Complex-The stability of a complex whose more stabilizing interaction involves an ionized phosphate group is expected to strongly depend on the ionic strength. We have examined this matter by measuring the stability of the wild type apoflavodoxin complex as a function of ionic strength from 2 mM to 500 mM (Table III ). The complex is maximally stable at low ionic strength, and it becomes progressively destabilized as the ionic strength is increased. Unexpectedly, the stability difference between 2 and 500 mM ionic strength is small: just 0.7 kcal mol Ϫ1 . Interestingly, the apoflavodoxin-riboflavin complex behaves in the opposite way (Table  III) ; it is weakest at 2 mM ionic strength and becomes more stable as the ionic strength is increased. The stability difference for this complex (2.6 kcal mol Ϫ1 ) is thus greater than that of the FMN complex. The more likely explanation of the salt induced stabilization of the apoflavodoxin-riboflavin complex is that this complex is strongly stabilized by the hydrophobic effect manifested upon burial of the isoalloxazine ring within the protein. Since the apoflavodoxin-FMN complex must also be similarly stabilized by the hydrophobic effect, increasing the ionic strength is likely to exert two opposing effects on the stability of the apoflavodoxin-FMN complex; on the one hand, salt will stabilize the complex by strengthening the hydrophobic effect, and, on the other hand, salt will weaken the complex by interfering with phosphate binding. For these reasons the small destabilizing effect exerted by ionic strength on the stability of the apoflavodoxin-FMN complex is a balance between two opposing effects and does not correspond with the effect of salt on the binding of phosphate, which is thus expected to be higher than the reported 0.7 kcal mol Ϫ1 .
When the binding energies of the flavodoxin-FMN complexes in 50 mM Mops, pH 7.0, reported here and the corresponding energies determined in 50 mM potassium phosphate (4) are compared, it turns out that, despite the higher ionic strength of the phosphate buffer that exerts a destabilizing effect, the complexes are in most cases somewhat more stable in phosphate than in Mops (0.4 kcal mol Ϫ1 on average). To investigate this effect, we have measured the binding energy of the wild type apoflavodoxin complex at various phosphate concentrations (at a constant ionic strength of 500 mM; Table IV ). Our results indicate that 10 mM sodium phosphate stabilizes the apoflavodoxin-FMN complex by 1.4 kcal mol Ϫ1 and that a higher phosphate concentration of 100 mM weakens the complex. This effect indicates that phosphate can bind to apoflavodoxin at those concentrations, but the interpretation is not straightforward; if the binding occurs at the FMN phosphate binding site (as observed in the x-ray structure of wild type and W57A apoflavodoxin; see Ref. 14 and this work), the phosphate should act as a competitive inhibitor, lowering the affinity of FMN. Although a different phosphate binding site has been observed in a structure of holoflavodoxin (13) , it seems to be formed as a consequence of crystal packing interactions and it is thus unlikely to be present in our solution conditions where apoflavodoxin is monomeric.
When the influence of phosphate, at constant ionic strength, on the apoflavodoxin-riboflavin complex is measured, no change in the stability is observed from 0 to 100 mM phosphate (Table IV) , in contrast with data reported for D. vulgaris flavodoxin (9) . The lack of a phosphate effect on the stability of the Anabaena apoflavodoxin-riboflavin complex makes unlikely that the binding of phosphate to the FMN-phosphate binding site of Anabaena flavodoxin significantly reorganizes the isoalloxazine binding site. The isoalloxazine and the phosphate binding site of Anabaena flavodoxin would thus not be coupled in the oxidized complex.
Enthalpic and Entropic Contributions to the Apoflavodoxin-FMN Complexes-The wild type apoflavodoxin-FMN complex is stabilized by both enthalpy and entropy, the enthalpic component being dominant. Comparison of the enthalpy changes of the FMN and riboflavin wild type complexes suggests that half of the enthalpy change may be attributed to the hydrogen bonds formed by the phosphate, and the other half to van der Waals interactions between the rest of the FMN molecule, particularly the isoalloxazine, and the protein. As for the small entropic contribution to the stability of the FMN complex it may reflect a compensation between the hydrophobic effect and the loss of translational, rotational and conformational entropy associated to complex formation.
Although a detailed analysis of the effect of each mutation on the entropy/enthalpy balance of the complex is difficult in the absence of more structural information, one general feature is, however, evident. Despite the fact that mutations at positions 57 and 94 lower similarly the stability of the FMN complex, their effect on the entropy/enthalpy balance is different. Mutation of Tyr-94 does not change much this balance, leaving the enthalpy as the major source of stability. Mutation of Trp-57, however, markedly decreases the enthalpic contribution and, at the same time, increases the entropic one. One possible explanation is that the residues that replace the tryptophan form only weak interactions with bound FMN. In this respect, at least one hydrogen bond formed between the side chain Trp-57 nitrogen and the ribityl will not be present in the mutants. As for the increase in entropic stabilization upon Trp-57 replacement, it could be connected to the fact that in wild type apoflavodoxin there is a Trp-57/Tyr-94 hydrophobic contact that is broken upon complex formation. This could decrease the entropic stabilization of the wild type complex relative to mutant complexes (the studied mutations at posi-tion 94 probably display hydrophobic contacts similar to wild type).
Applicability of Certain ⌬ASA Parametrizations to the Binding of Ionic Ligands-In general, the large and negative ⌬ASA ap , ⌬ASA pol , and ⌬S conf values obtained for FMN binding to apoflavodoxin suggest that a huge concomitant conformational change takes place, which does not seem compatible with the available structures of holo and apoflavodoxin (12, 14) . In fact, the apoflavodoxin structure is quite similar to that of the holoprotein, with an aromatic/aromatic interaction between the indole ring of tryptophan 57 and the phenyl ring of tyrosine 94 that closes the cleft where the cofactor binds in the holo form. Calculations of accessible surface areas in apo and holoflavodoxin (using WHAT IF; Ref. 43 ) have led us to values for ⌬ASA (polar ϩ apolar) of Ϫ400 Å 2 , 1 order of magnitude lower than the values calculated from Equations 2 and 3 (Table VII) . One possible explanation for this discrepancy could be related to the fact that a sulfate ion is found in the FMN phosphate binding site in the crystal structure of apoflavodoxin (14) . In the absence of high sulfate concentration (calorimetric experiments), this region could be less organized than in the crystal structure. A severe disorganization of this region that could account for the huge loss of exposed surface area calculated is, however, difficult to reconcile with the spectroscopic and thermodynamic evidence, which indicates that apoflavodoxin is a well folded protein in the absence of sulfate or phosphate. Unrealistic changes in surface areas upon ligand binding calculated from thermodynamic data have already been reported before for another protein (44) . These authors, in a study of the binding of Na ϩ to thrombin, found that the heat capacity change was very high and suggested that the reason might be a concomitant ordering of water molecules upon complex formation. It is not clear that the same occurs in the apoflavodoxin-FMN complex. Anyhow, since the phosphate in FMN makes a major contribution to the energetics of the apoflavodoxin/FMN complex, both the flavodoxin and the thrombin complexes are dominated by the interaction of an ion with the protein. We suggest that the unrealistic changes in surface areas calculated using Equations 2 and 3 might reflect that these equations are not generally applicable to the binding of ionic ligands.
